Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$113.42 -0.53 (-0.47%)
As of: Nov 11, 2026 · 3:48 PM EST

Rhythm Pharmaceuticals (RYTM) Return on Equity [ROE] (2017 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Return on Equity [ROE] of -203.00% for Q3 2026, up 77.99 percentage points from -280.98% a year earlier but down 21.19 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Return on Equity [ROE] (2017 - 2026) Analysis & Trends

For FY2025, Rhythm Pharmaceuticals posted Return on Equity [ROE] of -244.45%, up 27.73 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of -184.57 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -272.19% in FY2024 (-187.09 pp), -85.10% in FY2023 (-19.05 pp), -66.05% in FY2022 (-35.16 pp) and -30.89% in FY2021 (+28.99 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -5201.96% in Q2 2025 and a high of -22.96% in Q4 2021.
  • Year over year, Return on Equity [ROE] has now increased in each of the last five quarters, with an average year-over-year change of +149.96 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 5020.15 percentage points); the low point was Q2 2025 (a drop of 4687.81 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -181.81% (Q2 2026), -154.73% (Q1 2026) and -136.55% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Rhythm Pharmaceuticals 7.90 Bn 6.52 Bn 79.96 Mn -205.25%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -205.25%
Jun 30, 2026 -183.03%
Mar 31, 2026 -157.45%
Dec 31, 2025 -140.80%
Sep 30, 2025 -289.29%
Jun 30, 2025 -5,399.46%
Mar 31, 2025 -854.83%
Dec 31, 2024 -1,607.03%
Sep 30, 2024 -1,036.55%
Jun 30, 2024 -517.88%
Mar 31, 2024 -236.92%
Dec 31, 2023 -100.46%
Sep 30, 2023 -97.59%
Jun 30, 2023 -90.21%
Mar 31, 2023 -74.34%
Dec 31, 2022 -66.44%
Sep 30, 2022 -76.22%
Jun 30, 2022 -81.84%
Mar 31, 2022 -64.07%
Dec 31, 2021 -22.93%
API Access

Rhythm Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RYTM&period=max&api_key=YOUR_API_KEY